ClinicalTrials.gg
Status unknownNCT03560388Updated Aug 21, 2024

Acupuncture and Integrative Care in Gynecological Surgery

An interventional study of Acupuncture and touch/relaxation in Quality of Life, sponsored by Carmel Medical Center. Status unknown at 1 site in Israel. Open to female participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-08-21.

Sponsored by Carmel Medical Center · Not applicable, Interventional, and Supportive care

The sponsor has not verified this record recently (last verified Aug 2024), so the status shown — last known as Recruiting — may be out of date.
Phase
Not applicable
Study type
Interventional
Enrollment
135
Allocation
Randomized
Ages
18 Years and older
Sex
Female
01

Study summary

Patients undergoing surgical procedures for gynecological cancer are frequently challenged by intense anxiety prior to surgery, reflecting the accompanying uncertainty regarding the diagnosis, treatment and prognosis of their illness.The purpose of the proposed study is to explore the impact of complementary and integrative medicine (CIM) treatments (including acupuncture) on anxiety, pain, and general QOL of patients referred to gynecological oncology surgery. The investigators working hypothesis is that an intensive CIM treatment program, provided to patients within 24 hours prior to and during surgery will reduce perioperative anxiety and pain, and will reduce the need for intra-operative and post-operative analgesia.

Read the detailed description

Patients undergoing surgical procedures for gynecological cancer are frequently challenged by intense anxiety prior to surgery, reflecting the accompanying uncertainty regarding the diagnosis, treatment and prognosis of their illness. Following operation, pain and other quality of life-related concerns further exacerbate the emotional distress, which may itself aggravate pain and other symptoms. Clinical, controlled studied among patients with gynecological cancer undergoing chemotherapy had demonstrated effectiveness of complementary and integrative medicine (CIM) treatments for improving quality of life (QOL) and related symptoms, such as pain, gastro-intestinal concerns, fatigue, and anxiety.

The purpose of the proposed study is to explore the impact of CIM treatments (including acupuncture) on anxiety, pain, and general QOL of patients referred to gynecological oncology surgery. The investigators' working hypothesis is that an intensive CIM treatment program, provided to patients within 24 hours prior to and during surgery will reduce perioperative anxiety and pain, and will reduce the need for intra-operative and post-operative analgesia.

02

Conditions studied

  • Quality of Life

Keywords

  • Integrative medicine
  • Acupuncture
  • Gynecological oncology
  • Surgery
  • Analgesia
  • Pain
  • Anxiety
03

In context

Agnosia

1,269 studies on the registry are indexed under Agnosia; 524 are open to participants now.

This study's planned enrollment of 135 is above the median of 75 across 1,089 interventional studies indexed under Agnosia.

Browse Agnosia studies →

Lead sponsor

Carmel Medical Center is the lead sponsor of 119 studies on the registry; 7 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
Female
Accepts healthy volunteers
Yes

Eligibility criteria

Inclusion Criteria: Female patients age ≥ 18 years, who were referred to surgery for suspected/established gynecological-oncology cancer at the Carmel Medical Center; Patients diagnosed with class1-3 peri-operative risk according to American Society of Anesthesia.

Exclusion Criteria:Unwillingness to sign the research participation form and/or limitations in comprehending the informed consent; during pregnancy; patients with chronic pain treated with opiates within one month preceding surgery.

05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Triple (Participant, Care provider, Investigator)
Enrollment
135 participants (estimated)

Study arms

  • No intervention
    Control

    Control group include participants randomly allocated to supportive care (with no added integrative care or acupuncture)

  • Experimental
    Touch/relaxation

    Touch/relaxation treatment (pre-operative)

    Other: Acupuncture and touch/relaxation

  • Experimental
    Acupuncture and touch/relaxation

    Acupuncture (intra operative) and touch-relaxation treatment (pre-operative)

    Other: Acupuncture and touch/relaxation

Interventions

  • OtherAcupuncture and touch/relaxation

    Pre-operative integrative care (touch-relaxation) that follows with intra-operative acupuncture

06

What researchers measure

Primary outcomes

  1. Pain assessment change

    Pain assessment on a visual analogue scale

    Time frame: Change from pre- (1 hour before) to post-operative (24 hours following surgery)

Secondary outcomes

  1. Anxiety assessment change

    Anxiety assessment on a visual analogue scale

    Time frame: Change from pre- (1 hour before) to post-operative (24 hours following surgery)

  2. Reduced analgesics use

    Monitoring intra- and post-operative analgesia use

    Time frame: During surgery (4-6 hours) and 24-hour post-surgery

07

Study locations

1 of 1 sites recruiting
  • Carmel Medical center
    Haifa, 35152, Israel
    • Eran Ben-Arye, MD · Contact · eranbe@clalit.org.il · 972528709282
    • Eran Ben-Arye · Principal investigator
    Recruiting
08

References and documents

Publications

  • Segev Y, Abofol S, Samuels N, Schmidt M, Assaf W, Ben-Arye E. Postoperative pain following intraoperative acupuncture: a randomized-controlled study. BMJ Support Palliat Care. 2025 Aug 26;15(5):642-647. doi: 10.1136/spcare-2025-005485. PubMed 40537176 ↗

Individual participant data

Plan to share: Undecided

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 21, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03560388
Responsible party
Eran Ben-Arye (Clinical Associate Professor, Carmel Medical Center) — Principal investigator
First posted
Jun 18, 2018
Start date
Jun 24, 2018
Primary completion
Aug 20, 2025 (estimated)
Completion
Dec 1, 2025 (estimated)
Last update
Aug 21, 2024

Study contacts

Eran Ben-Arye, MD
Contact
eranben@netvision.net.il
0528709282
Ofer Lavi, MD
Contact
lavi_ofer@clalit.org.il
Eran Ben-Arye, MD
principal investigator · Clalit Health Services

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Aug 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion